Developer of genetic testing kits designed to detect hereditary health issues.
Diagnostic Equipment📍 Burlingame, CA
Current Valuation
$4.6B
as of 2021-Q4
UNICORN
Developer of genetic testing kits designed to detect hereditary health issues.
Company Profile
HQ
Burlingame, CA
Employees
586
Total Raised
$336.9M
Last Round
Series E — $100M (Nov 2021)
IPO Status
private
Fundraising Status
Series E · $100M · 4y 9mo ago
privateTotal raised $336.9M
Secondary Market
Implied price / share
$12.24
Last round price / share
$99.97
vs last round
-87.8%
Open interest
4
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series E
$100M
Nov 2021
—
$4.6B
Health CareAppsBiotechnologyElectronic Health Record (EHR)Genetics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.